SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Tomasz Cierpicki, Jolanta Grembecka, Targeting protein–protein interactions in hematologic malignancies: still a challenge or a great opportunity for future therapies?, Immunological Reviews, 2015, 263, 1
  2. 2
    Arianna Loregian, Beatrice Mercorelli, Giulio Nannetti, Chiara Compagnin, Giorgio Palù, Antiviral strategies against influenza virus: towards new therapeutic approaches, Cellular and Molecular Life Sciences, 2014, 71, 19, 3659

    CrossRef

  3. 3
    Bruno O. Villoutreix, Melaine A. Kuenemann, Jean-Luc Poyet, Heriberto Bruzzoni-Giovanelli, Céline Labbé, David Lagorce, Olivier Sperandio, Maria A. Miteva, Drug-Like Protein[BOND]Protein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology, Molecular Informatics, 2014, 33, 6-7
  4. 4
    Arianna Loregian, Giorgio Palù, How academic labs can approach the drug discovery process as a way to synergize with big pharma, Trends in Microbiology, 2013, 21, 6, 261

    CrossRef

  5. 5
    Giorgio Palù, Arianna Loregian, Inhibition of herpesvirus and influenza virus replication by blocking polymerase subunit interactions, Antiviral Research, 2013, 99, 3, 318

    CrossRef

  6. 6
    Wenlong Lian, Punit Upadhyaya, Curran A. Rhodes, Yusen Liu, Dehua Pei, Screening Bicyclic Peptide Libraries for Protein–Protein Interaction Inhibitors: Discovery of a Tumor Necrosis Factor-α Antagonist, Journal of the American Chemical Society, 2013, 135, 32, 11990

    CrossRef

  7. 7
    Mark J. Landau, Hitesh Sharma, Karen S. Anderson, Selective peptide inhibitors of bifunctional thymidylate synthase-dihydrofolate reductase from Toxoplasma gondii provide insights into domain–domain communication and allosteric regulation, Protein Science, 2013, 22, 9
  8. 8
    Z. Yan, L. Guo, L. Hu, J. Wang, Specificity and affinity quantification of protein-protein interactions, Bioinformatics, 2013, 29, 9, 1127

    CrossRef

  9. 9
    Serena Massari, Giulio Nannetti, Laura Goracci, Luca Sancineto, Giulia Muratore, Stefano Sabatini, Giuseppe Manfroni, Beatrice Mercorelli, Violetta Cecchetti, Marzia Facchini, Giorgio Palù, Gabriele Cruciani, Arianna Loregian, Oriana Tabarrini, Structural Investigation of Cycloheptathiophene-3-carboxamide Derivatives Targeting Influenza Virus Polymerase Assembly, Journal of Medicinal Chemistry, 2013, 56, 24, 10118

    CrossRef

  10. 10
    Margit Schnee, Felicia M. Wagner, Ulrich H. Koszinowski, Zsolt Ruzsics, A cell free protein fragment complementation assay for monitoring the core interaction of the human cytomegalovirus nuclear egress complex, Antiviral Research, 2012, 95, 1, 12

    CrossRef

  11. 11
    Olivier Flusin, Laurent Saccucci, Céline Contesto-Richefeu, Amel Hamdi, Carine Bardou, Thomas Poyot, André Peinnequin, Jean-Marc Crance, Pierre Colas, Frédéric Iseni, A small molecule screen in yeast identifies inhibitors targeting protein–protein interactions within the vaccinia virus replication complex, Antiviral Research, 2012, 96, 2, 187

    CrossRef

  12. 12
    G. Muratore, L. Goracci, B. Mercorelli, A. Foeglein, P. Digard, G. Cruciani, G. Palu, A. Loregian, Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase, Proceedings of the National Academy of Sciences, 2012, 109, 16, 6247

    CrossRef

  13. 13
    Xiaoxi Shui, Xinhua Lu, Yan Gao, Chen Liu, Fengzhi Ren, Qin Jiang, Hua Zhang, Baohua Zhao, Zhihui Zheng, A mammalian two-hybrid system-based assay for small-molecular HIV fusion inhibitors targeting gp41, Antiviral Research, 2011, 90, 1, 54

    CrossRef

  14. 14
    Deborah Mai, Jennifer Jones, John W. Rodgers, John L. Hartman, Olaf Kutsch, Adrie J.C. Steyn, A Screen to Identify Small Molecule Inhibitors of Protein–Protein Interactions in Mycobacteria, ASSAY and Drug Development Technologies, 2011, 9, 3, 299

    CrossRef

  15. 15
    Beatrice Mercorelli, David Lembo, Giorgio Palù, Arianna Loregian, Early inhibitors of human cytomegalovirus: State-of-art and therapeutic perspectives, Pharmacology & Therapeutics, 2011, 131, 3, 309

    CrossRef

  16. 16
    James T. Heeres, Paul J. Hergenrother, High-throughput screening for modulators of protein–protein interactions: use of photonic crystal biosensors and complementary technologies, Chem. Soc. Rev., 2011, 40, 8, 4398

    CrossRef

  17. 17
    D. Cardinale, G. Guaitoli, D. Tondi, R. Luciani, S. Henrich, O. M. H. Salo-Ahen, S. Ferrari, G. Marverti, D. Guerrieri, A. Ligabue, C. Frassineti, C. Pozzi, S. Mangani, D. Fessas, R. Guerrini, G. Ponterini, R. C. Wade, M. P. Costi, Protein-protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase, Proceedings of the National Academy of Sciences, 2011, 108, 34, E542

    CrossRef

  18. 18
    Alexander Zhdanko, Anke Schmauder, Christopher I. Ma, L. David Sibley, David Sept, Florenz Sasse, Martin E. Maier, Synthesis of Chondramide A Analogues with Modified β-Tyrosine and Their Biological Evaluation, Chemistry - A European Journal, 2011, 17, 47
  19. 19
    Alexander B. Sigalov, Uncoupled binding and folding of immune signaling-related intrinsically disordered proteins, Progress in Biophysics and Molecular Biology, 2011, 106, 3, 525

    CrossRef

  20. 20
    Chan Li, Tummala R.K. Reddy, Peter M. Fischer, Lodewijk V. Dekker, A Cy5-Labeled S100A10 Tracer Used to Identify Inhibitors of the Protein Interaction With Annexin A2, ASSAY and Drug Development Technologies, 2010, 8, 1, 85

    CrossRef

  21. 21
    Alexander B. Sigalov, New therapeutic strategies targeting transmembrane signal transduction in the immune system, Cell Adhesion & Migration, 2010, 4, 2, 255

    CrossRef

  22. 22
    Guillaume Castel, Noël Tordo, Nouvelles stratégies pour la conception de molécules antivirales, Revue Francophone des Laboratoires, 2009, 2009, 417, 91

    CrossRef

  23. 23
    Giovanna Zinzalla, David E Thurston, Targeting protein–protein interactions for therapeutic intervention: a challenge for the future, Future Medicinal Chemistry, 2009, 1, 1, 65

    CrossRef

  24. 24
    J. Guo, X. Wu, D.-Y. Zhang, K. Lin, Genome-wide inference of protein interaction sites: lessons from the yeast high-quality negative protein-protein interaction dataset, Nucleic Acids Research, 2008, 36, 6, 2002

    CrossRef

  25. 25
    Beatrice Mercorelli, Elisa Sinigalia, Arianna Loregian, Giorgio Palù, Human cytomegalovirus DNA replication: antiviral targets and drugs, Reviews in Medical Virology, 2008, 18, 3
  26. 26
    Alexander B Sigalov, Novel mechanistic concept of platelet inhibition, Expert Opinion on Therapeutic Targets, 2008, 12, 6, 677

    CrossRef

  27. 27
    Fa Liu, Andrew G. Stephen, Abdul A. Waheed, M. Javad Aman, Eric O. Freed, Robert J. Fisher, Terrence R. Burke, SAR by Oxime-Containing Peptide Libraries: Application to Tsg101 Ligand Optimization, ChemBioChem, 2008, 9, 12
  28. 28
    Joseph Audie, Suzanne Scarlata, A novel empirical free energy function that explains and predicts protein–protein binding affinities, Biophysical Chemistry, 2007, 129, 2-3, 198

    CrossRef

  29. 29
    Matthew Siegel, Jiang Xia, Chaitan Khosla, Structure-based design of α-amido aldehyde containing gluten peptide analogues as modulators of HLA-DQ2 and transglutaminase 2, Bioorganic & Medicinal Chemistry, 2007, 15, 18, 6253

    CrossRef

  30. 30
    Matthew P. Badtke, Feng Cao, John E. Tavis, Combining genetic and biochemical approaches to identify functional molecular contact points, Biological Procedures Online, 2006, 8, 1, 77

    CrossRef

  31. 31
    María-José Camarasa, Sonsoles Velázquez, Ana San-Félix, María-Jesús Pérez-Pérez, Federico Gago, Dimerization inhibitors of HIV-1 reverse transcriptase, protease and integrase: A single mode of inhibition for the three HIV enzymes?, Antiviral Research, 2006, 71, 2-3, 260

    CrossRef

  32. 32
    H. Li, J. Li, L. Wong, Discovering motif pairs at interaction sites from protein sequences on a proteome-wide scale, Bioinformatics, 2006, 22, 8, 989

    CrossRef

  33. 33
    Alexander B. Sigalov, Immune cell signaling: a novel mechanistic model reveals new therapeutic targets, Trends in Pharmacological Sciences, 2006, 27, 10, 518

    CrossRef

  34. 34
    Ralf Schreck, Ulf R. Rapp, Raf kinases: Oncogenesis and drug discovery, International Journal of Cancer, 2006, 119, 10
  35. 35
    Annaliese K. Franz, Jared T. Shaw, Yuchen Tang, High-Throughput Methods of Chemical Synthesis Applied to the Preparation of Inhibitors of Protein–Protein Interactions,
  36. 36
    Mark W. Peczuh, Richard T. Desmond, Interface Peptides,
  37. 37
    James J. La Clair, On the Logic of Natural Product Binding in Protein–Protein Interactivity,